Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bausch + Lomb Corporation Common Shares (NY:BLCO)

14.94 -0.20 (-1.32%)
Official Closing Price Updated: 7:00 PM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 388,744
Open 15.21
Bid (Size) 14.00 (1)
Ask (Size) 16.00 (1)
Prev. Close 15.14
Today's Range 14.83 - 15.21
52wk Range 10.45 - 20.94
Shares Outstanding 354,200,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BLCO Q3 Deep Dive: Pharmaceuticals and Pipeline Drive Growth, Margin Initiatives Take Shape
Eyecare company Bausch + Lomb (NYSE:BLCO) met Wall Streets revenue expectations in Q3 CY2025, with sales up 7.1% year on year to $1.28 billion. The company’s outlook for the full year was close to... 
Via StockStory
Topics World Trade
Bausch + Lomb Corp (NYSE:BLCO) Q3 2025 Earnings: EPS Beat and Reaffirmed Guidance Drive Shares Higher
Bausch + Lomb (BLCO) Q3 2025 earnings beat EPS estimates by 11.9% and reaffirmed its full-year outlook, driving shares up in pre-market trading. 
Via Chartmill
Topics Earnings

Performance

YTD
-17.0%
-17.0%
1 Month
-0.9%
-0.9%
3 Month
+9.6%
+9.6%
6 Month
+28.9%
+28.9%
1 Year
-26.9%
-26.9%

More News

Read More
Bausch + Lomb (NYSE:BLCO) Reports Q3 In Line With Expectations, Stock Soars
Via StockStory
Earnings Scheduled For October 29, 2025
Via Benzinga
Bausch + Lomb Announces Third-Quarter 2025 Results
From Bausch + Lomb Corporation
Via Business Wire
Bausch + Lomb (BLCO) To Report Earnings Tomorrow: Here Is What To Expect
Via StockStory
Topics Artificial Intelligence
Bausch + Lomb (BLCO) Stock Is Up, What You Need To Know
Via StockStory
Topics Initial Public Offering World Trade
Activist Investor Turns Up Heat On Cooper, Urges Bausch + Lomb Merger To Boost Returns: Report
Via Stocktwits
3 Stocks Under $50 We Steer Clear Of
Via StockStory
Topics Economy Supply Chain
3 Unpopular Stocks Walking a Fine Line
Via StockStory
Bausch + Lomb Will Release Third-Quarter 2025 Financial Results on Oct. 29 and Hold Investor Day on Nov. 13
From Bausch + Lomb Corporation
Via Business Wire
1 Small-Cap Stock to Keep an Eye On and 2 That Underwhelm
Via StockStory
Bausch + Lomb, Enovis, and Haemonetics Shares Plummet, What You Need To Know
Via StockStory
Topics Economy Government World Trade
Bausch + Lomb Announces Publication of enVista Envy™ Full Range of Vision Intraocular Lens Pivotal U.S. Clinical Trial
From Bausch + Lomb Corporation
Via Business Wire
Bausch + Lomb Announces Publication of Data From a Prospective Study Evaluating the Efficacy of XIIDRA® in Alleviating Discomfort in Symptomatic Contact Lens Wearers
From Bausch + Lomb Corporation
Via Business Wire
Bausch + Lomb (BLCO) Stock Trades Up, Here Is Why
Via StockStory
Topics Economy Initial Public Offering Stocks
Bausch + Lomb Launches ASANA™ Gas Permeable Lenses in the United States
From Bausch + Lomb Corporation
Via Business Wire
3 Healthcare Stocks Walking a Fine Line
Via StockStory
Topics Stocks
Bausch + Lomb (BLCO) Stock Is Up, What You Need To Know
Via StockStory
Topics Economy Initial Public Offering Stocks
Purple, Bausch + Lomb, Etsy, Intel, and Camping World Shares Are Falling, What You Need To Know
Via StockStory
Topics Economy Stocks
Medical Devices & Supplies - Specialty Stocks Q2 Highlights: Bausch + Lomb (NYSE:BLCO)
Via StockStory
Bausch + Lomb Announces Board Changes
From Bausch + Lomb Corporation
Via Business Wire
1 Safe-and-Steady Stock with Competitive Advantages and 2 That Underwhelm
Via StockStory
Bausch + Lomb to Participate in Upcoming Investor Conferences
From Bausch + Lomb Corporation
Via Business Wire
Sotera Health Company, Incyte, Exact Sciences, Bausch + Lomb, and Addus HomeCare Shares Skyrocket, What You Need To Know
Via StockStory
Topics Economy Lawsuit

Frequently Asked Questions

Is Bausch + Lomb Corporation Common Shares publicly traded?
Yes, Bausch + Lomb Corporation Common Shares is publicly traded.
What exchange does Bausch + Lomb Corporation Common Shares trade on?
Bausch + Lomb Corporation Common Shares trades on the New York Stock Exchange
What is the ticker symbol for Bausch + Lomb Corporation Common Shares?
The ticker symbol for Bausch + Lomb Corporation Common Shares is BLCO on the New York Stock Exchange
What is the current price of Bausch + Lomb Corporation Common Shares?
The current price of Bausch + Lomb Corporation Common Shares is 14.94
When was Bausch + Lomb Corporation Common Shares last traded?
The last trade of Bausch + Lomb Corporation Common Shares was at 10/31/25 07:00 PM ET
What is the market capitalization of Bausch + Lomb Corporation Common Shares?
The market capitalization of Bausch + Lomb Corporation Common Shares is 5.29B
How many shares of Bausch + Lomb Corporation Common Shares are outstanding?
Bausch + Lomb Corporation Common Shares has 5B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.